Hepatic targeting of drugs and proteins by chemical modification
- 1 September 1995
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 36 (1-2) , 99-107
- https://doi.org/10.1016/0168-3659(95)00050-i
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Pharmacokinetics in design of polymeric drug delivery systemsJournal of Controlled Release, 1994
- Control of the disposition profiles of proteins in the kidney via chemical modificationJournal of Controlled Release, 1994
- Targeting Delivery of Protein Drugs by Chemical ModificationDrug Development and Industrial Pharmacy, 1994
- Therapeutic effects of superoxide dismutase derivatives modified with mono- or polysaccharides on hepatic injury induced by ischemia/reperfusionBiochemical and Biophysical Research Communications, 1992
- Tumor Localization and in vivo Antitumor Activity of the Immunoconjugate Composed of Anti‐human Colon Cancer Monoclonal Antibody and Mitomycin C‐Dextran ConjugateJapanese Journal of Cancer Research, 1991
- Physicochemical properties and antitumor activities of polymeric prodrugs of mitomycin C with different regeneration ratesJournal of Controlled Release, 1989
- Development of a novel polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate with anionic charge. II. Disposition and pharmacokinetics following intravenous and intramuscular administrationInternational Journal of Pharmaceutics, 1987
- Carbohydrate-Specific Receptors of the LiverAnnual Review of Biochemistry, 1982
- The preparation and labeling of DTPA-coupled albuminThe International Journal of Applied Radiation and Isotopes, 1982
- 2-Imino-2-methoxyethyl 1-thioglycosides: new reagents for attaching sugars to proteinsBiochemistry, 1976